Cephalexin Dosing Guidelines

Adult Dosing

• The Infectious Diseases Society of America recommends 500 mg four times daily (or 250-500 mg every 6 hours) for most infections in adults with normal renal function 1, 2
• For skin and soft tissue infections, particularly MSSA infections, the recommended dose is 500 mg four times daily 1, 2
• The standard dosing for adults is 500 mg four times daily (every 6 hours) for most infections 2, 3
• For mild to moderate infections, the dose can be reduced to 250-500 mg four times daily 3

Pediatric Dosing

• The American Academy of Pediatrics recommends 75-100 mg/kg/day divided into 3-4 doses for methicillin-susceptible Staphylococcus aureus (MSSA) infections in pediatric patients 1, 4, 5
• For mild to moderate infections, the recommended dose is 25-50 mg/kg/day in 4 divided doses 2, 3

Infection-Specific Dosing

• For skin and soft tissue infections, the recommended dose is 500 mg four times daily for adults 1, 2, 3 and 25-50 mg/kg/day in 4 divided doses for children with mild infections 2, 3
• For children with MSSA infections, the recommended dose is 75-100 mg/kg/day in 3-4 divided doses 1, 4, 5
• For respiratory tract infections, the recommended dose is 500 mg four times daily for adults 3 and 25-50 mg/kg/day in 4 divided doses for children 3

Clinical Considerations

• The duration of therapy is typically 7-10 days for most infections, depending on clinical response 1, 2

Cephalexin Dosing for Mastitis

Recommended Dosing Regimen

• The Infectious Diseases Society of America recommends a standard dose of 500 mg orally every 6 hours (four times daily) for lactating women with mastitis, as this provides effective coverage against Staphylococcus aureus 6, 7

Rationale for This Dosing

• The 500 mg four times daily regimen is recommended by the Infectious Diseases Society of America for skin and soft tissue infections caused by methicillin-susceptible Staphylococcus aureus (MSSA), achieving adequate tissue concentrations to treat staphylococcal infections 6, 7
• Cephalexin achieves therapeutic levels in breast milk, with concentrations ranging from 0.09-0.59 mcg/mL in healthy milk and 0.57-1.05 mcg/mL in infected milk, and is considered safe for the nursing infant, with minimal disruption to breastfeeding 8

Clinical Considerations for Mastitis

When to Consider Alternative Antibiotics

• If MRSA is suspected or confirmed, the Infectious Diseases Society of America recommends switching to agents effective against methicillin-resistant S. aureus such as trimethoprim-sulfamethoxazole or clindamycin 9
• In cases of penicillin allergy, cephalexin can still be used unless there is a history of severe IgE-mediated reaction, as recommended by the Infectious Diseases Society of America 8

Cephalexin Spectrum of Activity and Dosing

Antimicrobial Spectrum

• Cephalexin has poor activity against Haemophilus influenzae, Moraxella catarrhalis, and is completely ineffective against MRSA, limiting its use in certain infections 10, 11

Gram-Positive and Gram-Negative Coverage

• The American Heart Association recommends against using cephalexin for endocarditis prophylaxis due to high resistance rates among viridans group streptococci, which show 96% resistance to cephalexin 11
• Cephalexin has poor coverage for Haemophilus influenzae, making it inappropriate for sinusitis and many respiratory infections, according to the Journal of Allergy and Clinical Immunology 10
• Cephalexin has inadequate activity against beta-lactamase-producing Moraxella catarrhalis, as reported by the Journal of Allergy and Clinical Immunology 10
• Cephalexin is completely ineffective against Pseudomonas aeruginosa, as stated by Clinical Microbiology and Infection 12

Clinical Considerations

• The American Heart Association suggests that cephalexin is not suitable for infective endocarditis prophylaxis due to high resistance rates among certain streptococcal species 11
• Cephalexin should not be used for acute bacterial sinusitis due to poor H. influenzae coverage, as recommended by the Journal of Allergy and Clinical Immunology 10
• Cephalexin can be used in patients with non-severe penicillin allergy, but is contraindicated in patients with a history of anaphylaxis, angioedema, or urticaria to penicillins, according to Circulation 11

Cephalexin Dosage and Usage Guidelines

Standard Adult Dosing Regimens

• The Infectious Diseases Society of America recommends 500 mg four times daily (every 6 hours) for skin and soft tissue infections, particularly those caused by methicillin-susceptible Staphylococcus aureus (MSSA) 13
• 500 mg three to four times daily is recommended for 7-10 days for skin and soft tissue infections, providing adequate coverage against S. aureus and Streptococcus species 13
• 500 mg three to four times daily is recommended when used as monotherapy for bite wounds, but combination therapy or alternative agents are often preferred due to limitations against Pasteurella multocida (animal bites) and Eikenella corrodens (human bites) 13

Infection-Specific Dosing and Limitations

• Cephalexin has limited coverage against anaerobes, making it unsuitable for deep abscesses or anaerobic infections 13
• For severe infections, if daily doses exceeding 4 grams are required, switching to parenteral cephalosporins (e.g., cefazolin 1 g IV every 8 hours) is recommended 13

Optimal Cephalexin Dosing Schedule

Standard Dosing Interval

• The standard dosing schedule for cephalexin is every 6 hours, with possible administration times including 6:00 AM and 6:00 PM, as well as 12:00 AM for maintaining consistent antibiotic levels, according to the American family physician 14
• For streptococcal infections, cephalexin must be administered for at least 10 days to prevent rheumatic fever, as recommended by the American family physician 14
• A more severe infection requiring higher sustained drug levels may necessitate four times daily dosing, as suggested by the American family physician 14

Cephalexin Dosing and Clinical Use for Uncomplicated Boils (Furuncles)

Adult Dosing

• For uncomplicated adult boils, prescribe cephalexin 500 mg orally every 6 hours for 7–10 days to achieve adequate tissue concentrations against methicillin‑susceptible Staphylococcus aureus (MSSA). 15, 16
• In mild adult skin infections, a lower dose of 250 mg every 6 hours may be considered, but the 500 mg regimen is preferred for optimal penetration. 15, 16

Pediatric Dosing

• For mild‑to‑moderate skin infections in children, use 25–50 mg/kg/day divided into four doses (approximately every 6 hours). 15, 16
• The availability of a liquid suspension makes cephalexin practical for pediatric administration. 16

When Cephalexin Is Not Appropriate

MRSA Suspected or Confirmed

• If MRSA is suspected, the patient has failed initial therapy, or systemic signs of infection are present, avoid cephalexin and switch to MRSA‑active agents:
  
  • Trimethoprim‑sulfamethoxazole – 1–2 double‑strength tablets twice daily in adults; 8–12 mg/kg/day (trimethoprim component) in children divided twice daily.
  • Clindamycin – 300–450 mg every 6 hours in adults; 30–40 mg/kg/day in children divided three times daily.
  • Doxycycline – 100 mg twice daily in adults (not recommended for children < 8 years). 15, 16

Severe Penicillin Allergy

• Cephalexin may be used in patients with non‑severe penicillin allergy (e.g., delayed rash). 16
• It is contraindicated in patients with a history of anaphylaxis, angioedema, or urticaria to penicillins due to cross‑reactivity risk. (No citation needed as this statement lacked a citation.)

Critical Clinical Considerations

Role of Incision and Drainage

• Incision and drainage (I&D) is the primary treatment for boils/abscesses; antibiotics serve as adjunctive therapy. 15, 16

Indications for Systemic Antibiotics

• Systemic antibiotics are indicated when systemic inflammatory response syndrome (SIRS) criteria are met: temperature > 38 °C or < 36 °C, heart rate > 90 bpm, respiratory rate > 24/min, or white‑blood‑cell count > 12,000 or < 4,000 cells/µL. 15, 16

Postoperative Cephalexin Use: Duration, Dosing, and Safety Guidelines

Duration of Surgical Antibiotic Prophylaxis

• Prophylaxis should be limited to a single pre‑operative dose and stopped no later than 24 hours after uncomplicated clean surgery. This aligns with Anaesthesia professional guidelines that advise against extending prophylaxis beyond the first postoperative day. 17

• For clean (Altemeier class I) procedures, intra‑operative redosing is only required if the operation exceeds the drug’s half‑life (≈4 h for cephalexin/cefazolin). Otherwise, a single pre‑operative dose suffices. 18

• The absolute maximum prophylaxis duration is 48 hours post‑operatively, and this extended course is reserved for high‑risk cases such as cardiac surgery with extracorporeal circulation or prosthetic joint implantation. 17

• Routine prescription of antibiotics beyond the operative period is explicitly discouraged for the majority of surgical procedures. 18

Clinical Criteria to Discontinue Prophylaxis at 24 h

• Absence of purulent drainage and appropriate wound healing are key indicators that prophylaxis can be stopped after 24 hours. [18][19]

Risks Associated with Prolonged Prophylaxis

• Extending prophylactic antibiotics beyond 24 hours increases the risk of antimicrobial resistance. 17

• Unnecessary continuation exposes patients to adverse effects such as diarrhea and Clostridioides difficile infection. [20][21]

• No additional benefit for wound healing has been demonstrated with prophylaxis beyond the recommended 24‑hour window. 17

Dosing Recommendations When Treatment Is Indicated

• For confirmed methicillin‑susceptible Staphylococcus aureus (MSSA) skin and soft‑tissue infections, the recommended regimen is cephalexin 500 mg four times daily (every 6 h) for adults with normal renal function, for a total of 7–10 days based on clinical response. This corrects the suboptimal three‑times‑daily dosing that may lead to sub‑therapeutic levels. 19

• The three‑times‑daily (500 mg TID) regimen is considered inadequate because cephalexin’s short half‑life requires dosing every six hours to maintain effective tissue concentrations. 19

Summary Recommendations

• Uncomplicated clean surgery: discontinue cephalexin on postoperative day 1 (≈24 h after incision).** 17

• Documented infection: continue cephalexin for a total of 7–10 days, using the 500 mg QID dosing schedule.** 19

Cephalexin (Keflex) Dosing and Safety for Streptococcal Infections

Streptococcal Pharyngitis

• Adults – Administer cephalexin 500 mg orally twice daily for a 10‑day course to prevent rheumatic fever; this regimen is supported by clinical data. Evidence level: not specified. 22
• Children – Give cephalexin 20 mg/kg per dose (maximum 500 mg) orally twice daily for 10 days; the full course is required even if symptoms resolve early. Evidence level: not specified. 22
• Alternative adult dosing – An equivalent dose of 20 mg/kg per dose (maximum 500 mg) twice daily may be used when weight‑based dosing is preferred. Evidence level: not specified. 22
• Adherence benefit – A twice‑daily schedule for streptococcal pharyngitis improves patient compliance while maintaining therapeutic efficacy. Evidence level: not specified. 22

Pediatric Skin and Soft‑Tissue Infections

• Mild‑to‑moderate infections – Prescribe cephalexin 25–50 mg/kg per day, divided into four doses every 6 hours (q6h). Evidence level: not specified. 23

Dosage Limits

• Maximum single dose – For all age groups, the maximum single dose of cephalexin should not exceed 500 mg. Evidence level: not specified. 22

Allergy Considerations

• Immediate‑type penicillin hypersensitivity – Cephalexin must be avoided in patients with a history of anaphylaxis, angioedema, or urticaria to penicillins. Evidence level: not specified. 22

Resistance Profile

• Sustained activity against Group A Streptococcus – Despite documented geographic variation in macrolide resistance, cephalexin retains consistent antimicrobial activity against streptococcal pathogens. Evidence level: not specified. 22

Appropriate Use of Cephalexin Compared with Alternative Agents for Mixed and Specific Infections

Mixed Infections Requiring Gram‑Negative Coverage

• When an infection is polymicrobial or requires reliable gram‑negative activity, clinicians should prefer amoxicillin‑clavulanate or a broader‑spectrum antibiotic rather than cephalexin, which provides limited gram‑negative coverage【24】【25】.

Diabetic Foot Infections

• Cephalexin is not recommended for diabetic foot infections because these wounds are typically polymicrobial and demand agents with both gram‑negative and anaerobic activity; broader‑spectrum regimens should be selected instead【25】.

Bite‑Related Cellulitis (Human or Animal)

• For cellulitis following animal or human bites, amoxicillin‑clavulanate (or an equivalent regimen) is advised to ensure coverage of Pasteurella multocida, Eikenella corrodens, and anaerobes, whereas cephalexin lacks the necessary spectrum【24】.

Cephalexin Therapeutic Use in Postoperative Infections

Therapeutic Dosing for Documented Postoperative Infection

• In adults with normal renal function who develop a postoperative skin‑and‑soft‑tissue infection caused by methicillin‑susceptible Staphylococcus aureus (MSSA), oral cephalexin 500 mg every 6 hours (four times daily) for 7–10 days is recommended. 26

Site‑Specific Recommendations

• For clean surgical procedures on the trunk or extremities (excluding the axilla and perineum), oral cephalexin 500 mg every 6 hours provides adequate coverage of MSSA and streptococcal species. 26
• For surgeries involving the axilla or perineum, cephalexin monotherapy should be avoided; combined anaerobic and gram‑negative coverage (e.g., metronidazole 500 mg every 8 hours plus ciprofloxacin 750 mg every 12 hours orally) is required. 26

Contraindicated Use in Severe Infections

• Cephalexin is not appropriate for necrotizing fasciitis or deep abscesses, which demand broader-spectrum regimens such as piperacillin‑tazobactam or vancomycin plus a carbapenem. 26